PTC Therapeutics Inc
NASDAQ:PTCT

Watchlist Manager
PTC Therapeutics Inc Logo
PTC Therapeutics Inc
NASDAQ:PTCT
Watchlist
Price: 39.92 USD -1.82% Market Closed
Market Cap: 3.1B USD
Have any thoughts about
PTC Therapeutics Inc?
Write Note

PTC Therapeutics Inc
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

PTC Therapeutics Inc
Gross Profit Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
PTC Therapeutics Inc
NASDAQ:PTCT
Gross Profit
$831.6m
CAGR 3-Years
23%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Gross Profit
$36.7B
CAGR 3-Years
1%
CAGR 5-Years
8%
CAGR 10-Years
10%
Gilead Sciences Inc
NASDAQ:GILD
Gross Profit
$21.5B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
4%
Amgen Inc
NASDAQ:AMGN
Gross Profit
$19.6B
CAGR 3-Years
1%
CAGR 5-Years
0%
CAGR 10-Years
2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Gross Profit
$8.9B
CAGR 3-Years
15%
CAGR 5-Years
24%
CAGR 10-Years
28%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Gross Profit
$11.7B
CAGR 3-Years
3%
CAGR 5-Years
14%
CAGR 10-Years
18%

See Also

What is PTC Therapeutics Inc's Gross Profit?
Gross Profit
831.6m USD

Based on the financial report for Jun 30, 2024, PTC Therapeutics Inc's Gross Profit amounts to 831.6m USD.

What is PTC Therapeutics Inc's Gross Profit growth rate?
Gross Profit CAGR 5Y
26%

Over the last year, the Gross Profit growth was 8%. The average annual Gross Profit growth rates for PTC Therapeutics Inc have been 23% over the past three years , 26% over the past five years .

Back to Top